Threats Tagged 'cve-2026-50034'
View all threats tagged with 'cve-2026-50034'. Filter and sort to focus on specific types of threats.
Stop chasing alerts. Route them.
Start free, then upgrade once to turn Radar into an automated delivery engine for your security stack.
Custom feeds / Automations: email, Slack, webhooks, SIEM/MISP / API access (baseline limits)
API access activates after upgrading in Console -> Billing.
Check if your credentials are on the dark web
Instant breach scanning across billions of leaked records. Free tier available.
Filter Threats
Narrow down the results by type, severity, or affected countries
Threats Tagged 'cve-2026-50034'
Click on any threat for detailed analysis and mitigation recommendations
0 CVE-2026-50034 affects the Apollo Pharmacy Blood Glucose Monitoring System (Model No. APG-01 BT). An attacker within Bluetooth Low Energy (BLE) communication range can passively intercept wireless traffic and obtain sensitive health-related information, specifically glucose measurement values. This vulnerability is classified under CWE-319, indicating the transmission of sensitive information in an unprotected manner. The CVSS 3.1 base score is 6.5, reflecting a medium severity level. No patches or fixes are currently documented for this vulnerability. The device is not a cloud service, so remediation depends on vendor updates or device replacement. Join the discussion | GCVE Database | 06/18/2026, 23:47:13 UTC Added: 06/18/2026, 18:34:21 UTC |
Showing 1 to 1 of 1 result